Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).
Baars
J W
JW
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Wagstaff
J
J
Hack
C E
CE
Wolbink
G J
GJ
Eerenberg-Belmer
A J
AJ
Pinedo
H M
HM
D000799:Angioedema / Q000139:chemically induced*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D014581:Urticaria / Q000139:chemically induced*
D007376:Interleukin-2